<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34389060</PMID><DateCompleted><Year>2022</Year><Month>01</Month><Day>25</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2051-5960</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Aug</Month><Day>13</Day></PubDate></JournalIssue><Title>Acta neuropathologica communications</Title><ISOAbbreviation>Acta Neuropathol Commun</ISOAbbreviation></Journal><ArticleTitle>The pathogenic role of c-Kit+ mast cells in the spinal motor neuron-vascular niche in ALS.</ArticleTitle><Pagination><StartPage>136</StartPage><MedlinePgn>136</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">136</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s40478-021-01241-3</ELocationID><Abstract><AbstractText>Degeneration of motor neurons, glial cell reactivity, and vascular alterations in the CNS are important neuropathological features of amyotrophic lateral sclerosis (ALS). Immune cells trafficking from the blood also infiltrate the affected CNS parenchyma and contribute to neuroinflammation. Mast cells (MCs) are hematopoietic-derived immune cells whose precursors differentiate upon migration into tissues. Upon activation, MCs undergo degranulation with the ability to increase vascular permeability, orchestrate neuroinflammation and modulate the neuroimmune response. However, the prevalence, pathological significance, and pharmacology of MCs in the CNS of ALS patients remain largely unknown. In autopsy ALS spinal cords, we identified for the first time that MCs express c-Kit together with chymase, tryptase, and Cox-2 and display granular or degranulating morphology, as compared with scarce MCs in control cords. In ALS, MCs were mainly found in the niche between spinal motor neuron somas and nearby microvascular elements, and they displayed remarkable pathological abnormalities. Similarly, MCs accumulated in the motor neuron-vascular niche of ALS murine models, in the vicinity of astrocytes and motor neurons expressing the c-Kit ligand stem cell factor (SCF), suggesting an SCF/c-Kit-dependent mechanism of MC differentiation from precursors. Mechanistically, we provide evidence that fully differentiated MCs in cell cultures can be generated from the murine ALS spinal cord tissue, further supporting the presence of c-Kit+ MC precursors. Moreover, intravenous administration of bone marrow-derived c-Kit+ MC precursors infiltrated the spinal cord in ALS mice but not in controls, consistent with aberrant trafficking through a defective microvasculature. Pharmacological inhibition of c-Kit with masitinib in ALS mice reduced the MC number and the influx of MC precursors from the periphery. Our results suggest a previously unknown pathogenic mechanism triggered by MCs in the ALS motor neuron-vascular niche that might be targeted pharmacologically.</AbstractText><CopyrightInformation>&#xa9; 2021. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kovacs</LastName><ForeName>Mari&#xe1;ngeles</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institut Pasteur de Montevideo, 2020, Montevideo, Uruguay.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alam&#xf3;n</LastName><ForeName>Catalina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Institut Pasteur de Montevideo, 2020, Montevideo, Uruguay.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maciel</LastName><ForeName>Cecilia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Institut Pasteur de Montevideo, 2020, Montevideo, Uruguay.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Varela</LastName><ForeName>Valentina</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Institut Pasteur de Montevideo, 2020, Montevideo, Uruguay.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ibarburu</LastName><ForeName>Sof&#xed;a</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institut Pasteur de Montevideo, 2020, Montevideo, Uruguay.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tarrag&#xf3;</LastName><ForeName>Lucas</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Institut Pasteur de Montevideo, 2020, Montevideo, Uruguay.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>King</LastName><ForeName>Peter H</ForeName><Initials>PH</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Alabama, Birmingham, AL, 35294, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Birmingham Veterans Affairs Medical Center, Birmingham, AL, 35295, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Si</LastName><ForeName>Ying</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Alabama, Birmingham, AL, 35294, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Birmingham Veterans Affairs Medical Center, Birmingham, AL, 35295, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kwon</LastName><ForeName>Yuri</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Alabama, Birmingham, AL, 35294, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hermine</LastName><ForeName>Olivier</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Imagine Institute, H&#xf4;pital Necker, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>INSERM UMR 1163, Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutic Implications, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Imagine Institute, Paris Descartes-Sorbonne Paris Cit&#xe9; University, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CNRS ERL 8254, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Excellence GR-Ex, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Equipe Lab&#xe9;lis&#xe9;e par la Ligue Nationale contre le cancer; AB Science; Department of Hematology, Necker Hospital, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre national de r&#xe9;f&#xe9;rence des mastocytoses (CEREMAST), Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barbeito</LastName><ForeName>Luis</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Institut Pasteur de Montevideo, 2020, Montevideo, Uruguay.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trias</LastName><ForeName>Emiliano</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0001-7187-511X</Identifier><AffiliationInfo><Affiliation>Institut Pasteur de Montevideo, 2020, Montevideo, Uruguay. etrias@pasteur.edu.uy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>I01 BX001148</GrantID><Acronym>BX</Acronym><Agency>BLRD VA</Agency><Country>United States</Country></Grant><Grant><GrantID>I01 BX004419</GrantID><Acronym>BX</Acronym><Agency>BLRD VA</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS092651</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 NS111275</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>08</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Acta Neuropathol Commun</MedlineTA><NlmUniqueID>101610673</NlmUniqueID><ISSNLinking>2051-5960</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001549">Benzamides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010880">Piperidines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D047428">Protein Kinase Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011725">Pyridines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019089">Stem Cell Factor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D013844">Thiazoles</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.14.99.1</RegistryNumber><NameOfSubstance UI="D051546">Cyclooxygenase 2</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.10.1</RegistryNumber><NameOfSubstance UI="D019009">Proto-Oncogene Proteins c-kit</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.21.39</RegistryNumber><NameOfSubstance UI="D053818">Chymases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.21.59</RegistryNumber><NameOfSubstance UI="D053802">Tryptases</NameOfSubstance></Chemical><Chemical><RegistryNumber>M59NC4E26P</RegistryNumber><NameOfSubstance UI="C526575">masitinib</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001253" MajorTopicYN="N">Astrocytes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001549" MajorTopicYN="N">Benzamides</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053818" MajorTopicYN="N">Chymases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051546" MajorTopicYN="N">Cyclooxygenase 2</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008407" MajorTopicYN="N">Mast Cells</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055806" MajorTopicYN="N">Microvessels</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000090862" MajorTopicYN="N">Neuroinflammatory Diseases</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010880" MajorTopicYN="N">Piperidines</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D047428" MajorTopicYN="N">Protein Kinase Inhibitors</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019009" MajorTopicYN="N">Proto-Oncogene Proteins c-kit</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011725" MajorTopicYN="N">Pyridines</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013116" MajorTopicYN="N">Spinal Cord</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019089" MajorTopicYN="N">Stem Cell Factor</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013844" MajorTopicYN="N">Thiazoles</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053802" MajorTopicYN="N">Tryptases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">Masitinib</Keyword><Keyword MajorTopicYN="N">Mast cells</Keyword><Keyword MajorTopicYN="N">Motor neuron-vascular niche</Keyword><Keyword MajorTopicYN="N">Spinal cord</Keyword></KeywordList><CoiStatement>OH is a co-founder and shareholder of AB science. Others have no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>8</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>8</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>8</Month><Day>14</Day><Hour>5</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>8</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34389060</ArticleId><ArticleId IdType="pmc">PMC8361844</ArticleId><ArticleId IdType="doi">10.1186/s40478-021-01241-3</ArticleId><ArticleId IdType="pii">10.1186/s40478-021-01241-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ashina K, Tsubosaka Y, Nakamura T, Omori K, Kobayashi K, Hori M, Ozaki H, Murata T. Histamine induces vascular hyperpermeability by increasing blood flow and endothelial barrier disruption in vivo. PLoS ONE. 2015;10:e0132367. doi: 10.1371/journal.pone.0132367.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0132367</ArticleId><ArticleId IdType="pmc">PMC4497677</ArticleId><ArticleId IdType="pubmed">26158531</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbeito AG, Martinez-Palma L, Vargas MR, Pehar M, Manay N, Beckman JS, Barbeito L, Cassina P. Lead exposure stimulates VEGF expression in the spinal cord and extends survival in a mouse model of ALS. Neurobiol Dis. 2010;37:574&#x2013;580. doi: 10.1016/j.nbd.2009.11.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2009.11.007</ArticleId><ArticleId IdType="pmc">PMC2824063</ArticleId><ArticleId IdType="pubmed">19914377</ArticleId></ArticleIdList></Reference><Reference><Citation>Butovsky O, Siddiqui S, Gabriely G, Lanser AJ, Dake B, Murugaiyan G, Doykan CE, Wu PM, Gali RR, Iyer LK, et al. Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS. J Clin Invest. 2012;122:3063&#x2013;3087. doi: 10.1172/JCI62636.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI62636</ArticleId><ArticleId IdType="pmc">PMC3428086</ArticleId><ArticleId IdType="pubmed">22863620</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng LE, Hartmann K, Roers A, Krummel MF, Locksley RM. Perivascular mast cells dynamically probe cutaneous blood vessels to capture immunoglobulin E. Immunity. 2013;38:166&#x2013;175. doi: 10.1016/j.immuni.2012.09.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2012.09.022</ArticleId><ArticleId IdType="pmc">PMC3576928</ArticleId><ArticleId IdType="pubmed">23290520</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiot A, Zaidi S, Iltis C, Ribon M, Berriat F, Schiaffino L, Jolly A, de la Grange P, Mallat M, Bohl D, et al. Modifying macrophages at the periphery has the capacity to change microglial reactivity and to extend ALS survival. Nat Neurosci. 2020;23:1339&#x2013;1351. doi: 10.1038/s41593-020-00718-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-00718-z</ArticleId><ArticleId IdType="pubmed">33077946</ArticleId></ArticleIdList></Reference><Reference><Citation>Coque E, Salsac C, Espinosa-Carrasco G, Varga B, Degauque N, Cadoux M, Crabe R, Virenque A, Soulard C, Fierle JK, et al. Cytotoxic CD8(+) T lymphocytes expressing ALS-causing SOD1 mutant selectively trigger death of spinal motoneurons. Proc Natl Acad Sci U S A. 2019;116:2312&#x2013;2317. doi: 10.1073/pnas.1815961116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1815961116</ArticleId><ArticleId IdType="pmc">PMC6369778</ArticleId><ArticleId IdType="pubmed">30674678</ArticleId></ArticleIdList></Reference><Reference><Citation>Dahlin JS, Hallgren J. Mast cell progenitors: origin, development and migration to tissues. Mol Immunol. 2015;63:9&#x2013;17. doi: 10.1016/j.molimm.2014.01.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molimm.2014.01.018</ArticleId><ArticleId IdType="pubmed">24598075</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai H, Korthuis RJ. Mast Cell Proteases and Inflammation. Drug Discov Today Dis Models. 2011;8:47&#x2013;55. doi: 10.1016/j.ddmod.2011.06.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ddmod.2011.06.004</ArticleId><ArticleId IdType="pmc">PMC3223931</ArticleId><ArticleId IdType="pubmed">22125569</ArticleId></ArticleIdList></Reference><Reference><Citation>Dell'Italia LJ, Collawn JF, Ferrario CM. Multifunctional role of chymase in acute and chronic tissue injury and remodeling. Circ Res. 2018;122:319&#x2013;336. doi: 10.1161/CIRCRESAHA.117.310978.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.117.310978</ArticleId><ArticleId IdType="pmc">PMC5776735</ArticleId><ArticleId IdType="pubmed">29348253</ArticleId></ArticleIdList></Reference><Reference><Citation>Dimitriadou V, Rouleau A, Tuong MD, Ligneau X, Newlands GF, Miller HR, Schwartz JC, Garbarg M. Rat cerebral mast cells undergo phenotypic changes during development. Brain Res Dev Brain Res. 1996;97:29&#x2013;41. doi: 10.1016/s0165-3806(96)00127-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0165-3806(96)00127-7</ArticleId><ArticleId IdType="pubmed">8946052</ArticleId></ArticleIdList></Reference><Reference><Citation>Dubreuil P, Letard S, Ciufolini M, Gros L, Humbert M, Casteran N, Borge L, Hajem B, Lermet A, Sippl W, et al. Masitinib (AB1010), a potent and selective tyrosine kinase inhibitor targeting KIT. PLoS ONE. 2009;4:e7258. doi: 10.1371/journal.pone.0007258.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0007258</ArticleId><ArticleId IdType="pmc">PMC2746281</ArticleId><ArticleId IdType="pubmed">19789626</ArticleId></ArticleIdList></Reference><Reference><Citation>Elieh-Ali-Komi D, Cao Y. Role of mast cells in the pathogenesis of multiple sclerosis and experimental autoimmune encephalomyelitis. Clin Rev Allergy Immunol. 2017;52:436&#x2013;445. doi: 10.1007/s12016-016-8595-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12016-016-8595-y</ArticleId><ArticleId IdType="pubmed">28025778</ArticleId></ArticleIdList></Reference><Reference><Citation>Flanagan JG, Leder P. The kit ligand: a cell surface molecule altered in steel mutant fibroblasts. Cell. 1990;63:185&#x2013;194. doi: 10.1016/0092-8674(90)90299-t.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(90)90299-t</ArticleId><ArticleId IdType="pubmed">1698555</ArticleId></ArticleIdList></Reference><Reference><Citation>Florenzano F, Bentivoglio M. Degranulation, density, and distribution of mast cells in the rat thalamus: a light and electron microscopic study in basal conditions and after intracerebroventricular administration of nerve growth factor. J Comp Neurol. 2000;424:651&#x2013;669. doi: 10.1002/1096-9861(20000904)424:4&lt;651::AID-CNE7&gt;3.0.CO;2-G.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1096-9861(20000904)424:4&lt;651::AID-CNE7&gt;3.0.CO;2-G</ArticleId><ArticleId IdType="pubmed">10931487</ArticleId></ArticleIdList></Reference><Reference><Citation>Gama Sosa MA, Gasperi RD, Rocher AB, Wang AC, Janssen WG, Flores T, Perez GM, Schmeidler J, Dickstein DL, Hof PR, et al. Age-related vascular pathology in transgenic mice expressing presenilin 1-associated familial Alzheimer's disease mutations. Am J Pathol. 2010;176:353&#x2013;368. doi: 10.2353/ajpath.2010.090482.</Citation><ArticleIdList><ArticleId IdType="doi">10.2353/ajpath.2010.090482</ArticleId><ArticleId IdType="pmc">PMC2797896</ArticleId><ArticleId IdType="pubmed">20008141</ArticleId></ArticleIdList></Reference><Reference><Citation>Garbuzova-Davis S, Hernandez-Ontiveros DG, Rodrigues MC, Haller E, Frisina-Deyo A, Mirtyl S, Sallot S, Saporta S, Borlongan CV, Sanberg PR. Impaired blood-brain/spinal cord barrier in ALS patients. Brain Res. 2012;1469:114&#x2013;128. doi: 10.1016/j.brainres.2012.05.056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2012.05.056</ArticleId><ArticleId IdType="pubmed">22750125</ArticleId></ArticleIdList></Reference><Reference><Citation>Garbuzova-Davis S, Sanberg PR. Blood-CNS barrier impairment in ALS patients versus an animal model. Front Cell Neurosci. 2014;8:21. doi: 10.3389/fncel.2014.00021.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2014.00021</ArticleId><ArticleId IdType="pmc">PMC3910123</ArticleId><ArticleId IdType="pubmed">24550780</ArticleId></ArticleIdList></Reference><Reference><Citation>Garofalo S, Cocozza G, Porzia A, Inghilleri M, Raspa M, Scavizzi F, Aronica E, Bernardini G, Peng L, Ransohoff RM, et al. Natural killer cells modulate motor neuron-immune cell cross talk in models of Amyotrophic Lateral Sclerosis. Nat Commun. 2020;11:1773. doi: 10.1038/s41467-020-15644-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-15644-8</ArticleId><ArticleId IdType="pmc">PMC7156729</ArticleId><ArticleId IdType="pubmed">32286313</ArticleId></ArticleIdList></Reference><Reference><Citation>Graves MC, Fiala M, Dinglasan LA, Liu NQ, Sayre J, Chiappelli F, van Kooten C, Vinters HV. Inflammation in amyotrophic lateral sclerosis spinal cord and brain is mediated by activated macrophages, mast cells and T cells. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004;5:213&#x2013;219. doi: 10.1080/14660820410020286.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14660820410020286</ArticleId><ArticleId IdType="pubmed">15799549</ArticleId></ArticleIdList></Reference><Reference><Citation>Haig DM, Huntley JF, MacKellar A, Newlands GF, Inglis L, Sangha R, Cohen D, Hapel A, Galli SJ, Miller HR. Effects of stem cell factor (kit-ligand) and interleukin-3 on the growth and serine proteinase expression of rat bone-marrow-derived or serosal mast cells. Blood. 1994;83:72&#x2013;83. doi: 10.1182/blood.V83.1.72.72.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.V83.1.72.72</ArticleId><ArticleId IdType="pubmed">7506083</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrison JM, Rafuse VF. Muscle fiber-type specific terminal Schwann cell pathology leads to sprouting deficits following partial denervation in SOD1(G93A) mice. Neurobiol Dis. 2020;145:105052. doi: 10.1016/j.nbd.2020.105052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2020.105052</ArticleId><ArticleId IdType="pubmed">32827689</ArticleId></ArticleIdList></Reference><Reference><Citation>Hunter JM, Kwan J, Malek-Ahmadi M, Maarouf CL, Kokjohn TA, Belden C, Sabbagh MN, Beach TG, Roher AE. Morphological and pathological evolution of the brain microcirculation in aging and Alzheimer's disease. PLoS ONE. 2012;7:e36893. doi: 10.1371/journal.pone.0036893.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0036893</ArticleId><ArticleId IdType="pmc">PMC3353981</ArticleId><ArticleId IdType="pubmed">22615835</ArticleId></ArticleIdList></Reference><Reference><Citation>Isasi E, Barbeito L, Olivera-Bravo S. Increased blood-brain barrier permeability and alterations in perivascular astrocytes and pericytes induced by intracisternal glutaric acid. Fluids Barriers CNS. 2014;11:15. doi: 10.1186/2045-8118-11-15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2045-8118-11-15</ArticleId><ArticleId IdType="pmc">PMC4115159</ArticleId><ArticleId IdType="pubmed">25077029</ArticleId></ArticleIdList></Reference><Reference><Citation>Jesus S, Mora WGB, Chaverri D, Hern&#xe1;ndez-Barral M, Mascias J, Gamez J, Gargiulo-Monachelli GM, Moussy A, Mansfield CD, Hermine O, Ludolph AC. Long-term survival analysis of masitinib in amyotrophic lateral sclerosis. Ther Adv Neurol Disord. 2021 doi: 10.1177/17562864211030365.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/17562864211030365</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang SH, Fukaya M, Yang JK, Rothstein JD, Bergles DE. NG2+ CNS glial progenitors remain committed to the oligodendrocyte lineage in postnatal life and following neurodegeneration. Neuron. 2010;68:668&#x2013;681. doi: 10.1016/j.neuron.2010.09.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2010.09.009</ArticleId><ArticleId IdType="pmc">PMC2989827</ArticleId><ArticleId IdType="pubmed">21092857</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalil M, Ronda J, Weintraub M, Jain K, Silver R, Silverman AJ. Brain mast cell relationship to neurovasculature during development. Brain Res. 2007;1171:18&#x2013;29. doi: 10.1016/j.brainres.2007.07.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2007.07.034</ArticleId><ArticleId IdType="pmc">PMC2049068</ArticleId><ArticleId IdType="pubmed">17764664</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitamura Y, Oboki K, Ito A. Molecular mechanisms of mast cell development. Immunol Allergy Clin North Am. 2006;26(387&#x2013;405):v. doi: 10.1016/j.iac.2006.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.iac.2006.05.004</ArticleId><ArticleId IdType="pubmed">16931285</ArticleId></ArticleIdList></Reference><Reference><Citation>Kovacs M, Trias E, Varela V, Ibarburu S, Beckman JS, Moura IC, Hermine O, King PH, Si Y, Kwon Y, et al. CD34 identifies a subset of proliferating microglial cells associated with degenerating motor neurons in ALS. Int J Mol Sci. 2019 doi: 10.3390/ijms20163880.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20163880</ArticleId><ArticleId IdType="pmc">PMC6720880</ArticleId><ArticleId IdType="pubmed">31395804</ArticleId></ArticleIdList></Reference><Reference><Citation>Kritas SK, Caraffa A, Antinolfi P, Saggini A, Pantalone A, Rosati M, Tei M, Speziali A, Saggini R, Pandolfi F, et al. Nerve growth factor interactions with mast cells. Int J Immunopathol Pharmacol. 2014;27:15&#x2013;19. doi: 10.1177/039463201402700103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/039463201402700103</ArticleId><ArticleId IdType="pubmed">24674674</ArticleId></ArticleIdList></Reference><Reference><Citation>Kunder CA, St John AL, Abraham SN. Mast cell modulation of the vascular and lymphatic endothelium. Blood. 2011;118:5383&#x2013;5393. doi: 10.1182/blood-2011-07-358432.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2011-07-358432</ArticleId><ArticleId IdType="pmc">PMC3217344</ArticleId><ArticleId IdType="pubmed">21908429</ArticleId></ArticleIdList></Reference><Reference><Citation>Lambracht-Hall M, Dimitriadou V, Theoharides TC. Migration of mast cells in the developing rat brain. Brain Res Dev Brain Res. 1990;56:151&#x2013;159. doi: 10.1016/0165-3806(90)90077-c.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0165-3806(90)90077-c</ArticleId><ArticleId IdType="pubmed">2261679</ArticleId></ArticleIdList></Reference><Reference><Citation>Mora JS, Genge A, Chio A, Estol CJ, Chaverri D, Hernandez M, Marin S, Mascias J, Rodriguez GE, Povedano M, et al. Masitinib as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomized clinical trial. Amyotroph Lateral Scler Frontotemporal Degener. 2020;21:5&#x2013;14. doi: 10.1080/21678421.2019.1632346.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2019.1632346</ArticleId><ArticleId IdType="pubmed">31280619</ArticleId></ArticleIdList></Reference><Reference><Citation>Murdock BJ, Famie JP, Piecuch CE, Raue KD, Mendelson FE, Pieroni CH, Iniguez SD, Zhao L, Goutman SA, Feldman EL. NK cells associate with ALS in a sex- and age-dependent manner. JCI Insight. 2021 doi: 10.1172/jci.insight.147129.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.147129</ArticleId><ArticleId IdType="pmc">PMC8262328</ArticleId><ArticleId IdType="pubmed">33974561</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelissen S, Lemmens E, Geurts N, Kramer P, Maurer M, Hendriks J, Hendrix S. The role of mast cells in neuroinflammation. Acta Neuropathol. 2013;125:637&#x2013;650. doi: 10.1007/s00401-013-1092-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1092-y</ArticleId><ArticleId IdType="pubmed">23404369</ArticleId></ArticleIdList></Reference><Reference><Citation>Norrby K. Mast cells and angiogenesis. APMIS. 2002;110:355&#x2013;371. doi: 10.1034/j.1600-0463.2002.100501.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1034/j.1600-0463.2002.100501.x</ArticleId><ArticleId IdType="pubmed">12076253</ArticleId></ArticleIdList></Reference><Reference><Citation>Okayama Y, Kawakami T. Development, migration, and survival of mast cells. Immunol Res. 2006;34:97&#x2013;115. doi: 10.1385/IR:34:2:97.</Citation><ArticleIdList><ArticleId IdType="doi">10.1385/IR:34:2:97</ArticleId><ArticleId IdType="pmc">PMC1490026</ArticleId><ArticleId IdType="pubmed">16760571</ArticleId></ArticleIdList></Reference><Reference><Citation>Pehar M, Vargas MR, Cassina P, Barbeito AG, Beckman JS, Barbeito L. Complexity of astrocyte-motor neuron interactions in amyotrophic lateral sclerosis. Neurodegener Dis. 2005;2:139&#x2013;146. doi: 10.1159/000089619.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000089619</ArticleId><ArticleId IdType="pubmed">16909019</ArticleId></ArticleIdList></Reference><Reference><Citation>Piette F, Belmin J, Vincent H, Schmidt N, Pariel S, Verny M, Marquis C, Mely J, Hugonot-Diener L, Kinet JP, et al. Masitinib as an adjunct therapy for mild-to-moderate Alzheimer's disease: a randomised, placebo-controlled phase 2 trial. Alzheimers Res Ther. 2011;3:16. doi: 10.1186/alzrt75.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/alzrt75</ArticleId><ArticleId IdType="pmc">PMC3226277</ArticleId><ArticleId IdType="pubmed">21504563</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu FH, Ray P, Brown K, Barker PE, Jhanwar S, Ruddle FH, Besmer P. Primary structure of c-kit: relationship with the CSF-1/PDGF receptor kinase family&#x2013;oncogenic activation of v-kit involves deletion of extracellular domain and C terminus. EMBO J. 1988;7:1003&#x2013;1011. doi: 10.1002/j.1460-2075.1988.tb02907.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/j.1460-2075.1988.tb02907.x</ArticleId><ArticleId IdType="pmc">PMC454427</ArticleId><ArticleId IdType="pubmed">2456920</ArticleId></ArticleIdList></Reference><Reference><Citation>Ribatti D. The crucial role of mast cells in blood-brain barrier alterations. Exp Cell Res. 2015;338:119&#x2013;125. doi: 10.1016/j.yexcr.2015.05.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexcr.2015.05.013</ArticleId><ArticleId IdType="pubmed">26004870</ArticleId></ArticleIdList></Reference><Reference><Citation>Ribatti D. The Staining of Mast Cells: A Historical Overview. Int Arch Allergy Immunol. 2018;176:55&#x2013;60. doi: 10.1159/000487538.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000487538</ArticleId><ArticleId IdType="pubmed">29597213</ArticleId></ArticleIdList></Reference><Reference><Citation>Skaper SD, Facci L, Giusti P. Glia and mast cells as targets for palmitoylethanolamide, an anti-inflammatory and neuroprotective lipid mediator. Mol Neurobiol. 2013;48:340&#x2013;352. doi: 10.1007/s12035-013-8487-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-013-8487-6</ArticleId><ArticleId IdType="pubmed">23813098</ArticleId></ArticleIdList></Reference><Reference><Citation>Skaper SD, Facci L, Giusti P. Mast cells, glia and neuroinflammation: partners in crime? Immunology. 2014;141:314&#x2013;327. doi: 10.1111/imm.12170.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imm.12170</ArticleId><ArticleId IdType="pmc">PMC3930370</ArticleId><ArticleId IdType="pubmed">24032675</ArticleId></ArticleIdList></Reference><Reference><Citation>Skaper SD, Facci L, Zusso M, Giusti P. Neuroinflammation, Mast Cells, and Glia: Dangerous Liaisons. Neuroscientist. 2017;23:478&#x2013;498. doi: 10.1177/1073858416687249.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1073858416687249</ArticleId><ArticleId IdType="pubmed">29283023</ArticleId></ArticleIdList></Reference><Reference><Citation>Teodosio C, Garcia-Montero AC, Jara-Acevedo M, Sanchez-Munoz L, Alvarez-Twose I, Nunez R, Schwartz LB, Walls AF, Escribano L, Orfao A (2010) Mast cells from different molecular and prognostic subtypes of systemic mastocytosis display distinct immunophenotypes. J Allergy Clin Immunol 125: 719&#x2013;726, 726 e711&#x2013;726 e714. 10.1016/j.jaci.2009.10.020</Citation><ArticleIdList><ArticleId IdType="pubmed">20061010</ArticleId></ArticleIdList></Reference><Reference><Citation>Trias E, Diaz-Amarilla P, Olivera-Bravo S, Isasi E, Drechsel DA, Lopez N, Bradford CS, Ireton KE, Beckman JS, Barbeito L. Phenotypic transition of microglia into astrocyte-like cells associated with disease onset in a model of inherited ALS. Front Cell Neurosci. 2013;7:274. doi: 10.3389/fncel.2013.00274.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2013.00274</ArticleId><ArticleId IdType="pmc">PMC3871969</ArticleId><ArticleId IdType="pubmed">24399933</ArticleId></ArticleIdList></Reference><Reference><Citation>Trias E, Ibarburu S, Barreto-Nunez R, Babdor J, Maciel TT, Guillo M, Gros L, Dubreuil P, Diaz-Amarilla P, Cassina P, et al. Post-paralysis tyrosine kinase inhibition with masitinib abrogates neuroinflammation and slows disease progression in inherited amyotrophic lateral sclerosis. J Neuroinflammation. 2016;13:177. doi: 10.1186/s12974-016-0620-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-016-0620-9</ArticleId><ArticleId IdType="pmc">PMC4940876</ArticleId><ArticleId IdType="pubmed">27400786</ArticleId></ArticleIdList></Reference><Reference><Citation>Trias E, Ibarburu S, Barreto-Nunez R, Varela V, Moura IC, Dubreuil P, Hermine O, Beckman JS, Barbeito L. Evidence for mast cells contributing to neuromuscular pathology in an inherited model of ALS. JCI Insight. 2017 doi: 10.1172/jci.insight.95934.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.95934</ArticleId><ArticleId IdType="pmc">PMC5846907</ArticleId><ArticleId IdType="pubmed">29046475</ArticleId></ArticleIdList></Reference><Reference><Citation>Trias E, King PH, Si Y, Kwon Y, Varela V, Ibarburu S, Kovacs M, Moura IC, Beckman JS, Hermine O, et al. Mast cells and neutrophils mediate peripheral motor pathway degeneration in ALS. JCI Insight. 2018 doi: 10.1172/jci.insight.123249.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.123249</ArticleId><ArticleId IdType="pmc">PMC6237484</ArticleId><ArticleId IdType="pubmed">30282815</ArticleId></ArticleIdList></Reference><Reference><Citation>Trias E, Kovacs M, King PH, Si Y, Kwon Y, Varela V, Ibarburu S, Moura IC, Hermine O, Beckman JS, et al. Schwann cells orchestrate peripheral nerve inflammation through the expression of CSF1, IL-34, and SCF in amyotrophic lateral sclerosis. Glia. 2020;68:1165&#x2013;1181. doi: 10.1002/glia.23768.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23768</ArticleId><ArticleId IdType="pmc">PMC7269115</ArticleId><ArticleId IdType="pubmed">31859421</ArticleId></ArticleIdList></Reference><Reference><Citation>Trowbridge IS, Thomas ML. CD45: an emerging role as a protein tyrosine phosphatase required for lymphocyte activation and development. Annu Rev Immunol. 1994;12:85&#x2013;116. doi: 10.1146/annurev.iy.12.040194.000505.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.iy.12.040194.000505</ArticleId><ArticleId IdType="pubmed">8011300</ArticleId></ArticleIdList></Reference><Reference><Citation>Valent P, Akin C, Hartmann K, Nilsson G, Reiter A, Hermine O, Sotlar K, Sperr WR, Escribano L, George TI, et al. Mast cells as a unique hematopoietic lineage and cell system: from Paul Ehrlich's visions to precision medicine concepts. Theranostics. 2020;10:10743&#x2013;10768. doi: 10.7150/thno.46719.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/thno.46719</ArticleId><ArticleId IdType="pmc">PMC7482799</ArticleId><ArticleId IdType="pubmed">32929378</ArticleId></ArticleIdList></Reference><Reference><Citation>Vermersch P, Benrabah R, Schmidt N, Zephir H, Clavelou P, Vongsouthi C, Dubreuil P, Moussy A, Hermine O. Masitinib treatment in patients with progressive multiple sclerosis: a randomized pilot study. BMC Neurol. 2012;12:36. doi: 10.1186/1471-2377-12-36.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2377-12-36</ArticleId><ArticleId IdType="pmc">PMC3467179</ArticleId><ArticleId IdType="pubmed">22691628</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamadera M, Fujimura H, Inoue K, Toyooka K, Mori C, Hirano H, Sakoda S. Microvascular disturbance with decreased pericyte coverage is prominent in the ventral horn of patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16:393&#x2013;401. doi: 10.3109/21678421.2015.1011663.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2015.1011663</ArticleId><ArticleId IdType="pubmed">25740316</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou T, Zheng Y, Sun L, Badea SR, Jin Y, Liu Y, Rolfe AJ, Sun H, Wang X, Cheng Z, et al. Microvascular endothelial cells engulf myelin debris and promote macrophage recruitment and fibrosis after neural injury. Nat Neurosci. 2019;22:421&#x2013;435. doi: 10.1038/s41593-018-0324-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0324-9</ArticleId><ArticleId IdType="pmc">PMC6913093</ArticleId><ArticleId IdType="pubmed">30664769</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhuang X, Silverman AJ, Silver R. Distribution and local differentiation of mast cells in the parenchyma of the forebrain. J Comp Neurol. 1999;408:477&#x2013;488. doi: 10.1002/(sici)1096-9861(19990614)408:4&lt;477::aid-cne3&gt;3.0.co;2-o.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(sici)1096-9861(19990614)408:4&lt;477::aid-cne3&gt;3.0.co;2-o</ArticleId><ArticleId IdType="pubmed">10340499</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>